Basics Organon & Co.. IPO Date: May 14, 2021 Sector: Healthcare Industry: Drug Manufacturers - General Market Cap: $2.38B Activated in VL: True Average Daily Range Avg Daily Range: $0.37 | 1.62% Avg Daily Range (30 D): $0.32 | 3.36% Avg Daily Range (90 D): $0.34 | 2.71% Institutional Daily Volume Avg Daily Volume: 2.27M Avg Daily Volume (30 D): 6.5M Avg Daily Volume (90 D): 4.12M Trade Size Avg Trade Size (Sh.): 97 Avg Trade Size (Sh.) (30 D): 149 Avg Trade Size (Sh.) (90 D): 119 Institutional Trades Total Inst.Trades: 3,746 Avg Inst. Trade: $3.48M Avg Inst. Trade (30 D): $2.88M Avg Inst. Trade (90 D): $3.54M Avg Inst. Trade Volume: .16M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $8.21M Avg Closing Trade (30 D): $6.92M Avg Closing Trade (90 D): $8.13M Avg Closing Volume: 378.37K         News May 31, 2025 @ 3:30 PM OGN INVESTOR ALERT: Robbins Geller Rudman & Dowd L... Source: Robbins Geller Rudman & Dowd Llp May 31, 2025 @ 11:10 AM OGN CLASS NOTICE: Organon & Co. Investors may have... Source: N/A May 31, 2025 @ 1:00 AM ORGANON ALERT: Bragar Eagel & Squire, P.C. Announc... Source: N/A May 30, 2025 @ 4:39 PM Class Action Filed Against Organon & Co. (OGN) - J... Source: N/A May 30, 2025 @ 3:50 PM Shareholders who lost money on Organon & Co. (NYSE... Source: Wolf Haldenstein Adler Freeman & Herz Llp Financials   TTM Q1 2025 Q4 2024 Basic EPS $2.91 $.34 $.42 Diluted EPS $2.87 $.33 $.41 Revenue $ 6.29B $ 1.51B $ 1.59B Gross Profit $ 3.6B $ 841M $ 896M Net Income / Loss $ 750M $ 87M $ 109M Operating Income / Loss $ 672M $ 101M $ 129M Cost of Revenue $ 2.7B $ 672M $ 696M Net Cash Flow $ -28M $ -128M $ -88M PE Ratio 3.16